Clinical trial
Perifosine in Treating Patients With Recurrent, Refractory, Locally Advanced, or…
NCT00054145 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00054145 |
|---|---|
| Title | Perifosine in Treating Patients With Recurrent, Refractory, Locally Advanced, or Metastatic Breast Cancer |
| Official title | A Phase 2 Study Of Perifosine In Metastatic Or Advanced Breast Cancer |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | perifosine |
| Start date | Jun 1, 2003 |
| Primary completion | Apr 1, 2007 |
| First posted | Feb 6, 2003 |
| Last update posted | Jul 23, 2015 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: